NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
Last Earnings date
Sep'24
Q3 2024
($0.54)
6.5% beat
$4,675.0K
50.2% beat
Next quarter EPS Estimate
($0.09)
N/AYoY
PTGX Earnings and Expectations
Revenue
Crunching data... Almost there!
PTGX EPS (Earnings Per Share)
Crunching data... Almost there!
PTGX Historical Revenue & EPS and Expectations
Crunching data... Almost there!
PTGX Earnings History
Crunching data... Almost there!
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
Crunching data... Almost there!
Competing with PTGX Earnings
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
1. When was Protagonist Therapeutics, Inc.'s last earnings date?
Protagonist Therapeutics, Inc.'s last earnings date was Sep'24 (Q3 2024).
2. What is Protagonist Therapeutics, Inc.'s EPS, and was there a surprise?
Protagonist Therapeutics, Inc.'s EPS was ($0.54), with a 6.5% beat.
3. What is Protagonist Therapeutics, Inc.'s revenue, and was there a surprise?
Protagonist Therapeutics, Inc.'s revenue was $4,675.0K, with a 50.2% beat.
4. What is Protagonist Therapeutics, Inc.'s next quarter EPS estimate?
Protagonist Therapeutics, Inc.'s next quarter EPS estimate is ($0.09), with an expected N/A YoY growth.